Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience

M. Del Gaudio, G. Ercolani, M. Ravaioli, M. Cescon, A. Lauro, M. Vivarelli, M. Zanello, A. Cucchetti, G. Vetrone, F. Tuci, G. Ramacciato, G. L. Grazi, A. D. Pinna

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

Liver resection (LR) for patients with small hepatocellular carcinoma (HCC) with preserved liver function, employing liver transplantation (LT) as a salvage procedure (SLT) in the event of HCC recurrence, is a debated strategy. From 1996 to 2005, we treated 227 cirrhotic patients with HCC transplantable: 80 LRs and 147 LTs of 293 listed for transplantation. Among 80 patients eligible for transplantation who underwent LR, 39 (49%) developed HCC recurrence and 12/39 (31%) of these patients presented HCC recurrence outside Milan criteria. Only 10 of the 39 patients underwent LT, a transplantation rate of 26% of patients with HCC recurrence. According to intention-to-treat analysis of transplantable HCC patients who underwent LR (n = 80), compared to all those listed for transplantation (n = 293), 5-year overall survival was 66% in the LR group versus 58% in patients listed for LT, respectively (p = NS); 5-year disease-free survival was 41% in the LR group versus 54% in patients listed for LT (p = NS). Comparable 5-year overall (62% vs. 73%, p = NS) and disease-free (48% vs. 71%, p = NS) survival rates were obtained for SLT and primary LT for HCC, respectively. LR is a valid treatment for small HCC and in the event of recurrence, SLT is a safe and effective procedure.

Original languageEnglish
Pages (from-to)1177-1185
Number of pages9
JournalAmerican Journal of Transplantation
Volume8
Issue number6
DOIs
Publication statusPublished - Jun 2008

Fingerprint

Liver Cirrhosis
Liver Transplantation
Hepatocellular Carcinoma
Liver
Recurrence
Transplantation
Intention to Treat Analysis
Disease-Free Survival
Survival Rate
Survival

Keywords

  • Disease-free survival
  • Operative mortality
  • Outcome
  • Partial hepatectomy
  • Salvage transplantation

ASJC Scopus subject areas

  • Immunology

Cite this

Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection : University of Bologna experience. / Del Gaudio, M.; Ercolani, G.; Ravaioli, M.; Cescon, M.; Lauro, A.; Vivarelli, M.; Zanello, M.; Cucchetti, A.; Vetrone, G.; Tuci, F.; Ramacciato, G.; Grazi, G. L.; Pinna, A. D.

In: American Journal of Transplantation, Vol. 8, No. 6, 06.2008, p. 1177-1185.

Research output: Contribution to journalArticle

Del Gaudio, M, Ercolani, G, Ravaioli, M, Cescon, M, Lauro, A, Vivarelli, M, Zanello, M, Cucchetti, A, Vetrone, G, Tuci, F, Ramacciato, G, Grazi, GL & Pinna, AD 2008, 'Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience', American Journal of Transplantation, vol. 8, no. 6, pp. 1177-1185. https://doi.org/10.1111/j.1600-6143.2008.02229.x
Del Gaudio, M. ; Ercolani, G. ; Ravaioli, M. ; Cescon, M. ; Lauro, A. ; Vivarelli, M. ; Zanello, M. ; Cucchetti, A. ; Vetrone, G. ; Tuci, F. ; Ramacciato, G. ; Grazi, G. L. ; Pinna, A. D. / Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection : University of Bologna experience. In: American Journal of Transplantation. 2008 ; Vol. 8, No. 6. pp. 1177-1185.
@article{291a44e5fc6143f58b4d167e959d50b3,
title = "Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience",
abstract = "Liver resection (LR) for patients with small hepatocellular carcinoma (HCC) with preserved liver function, employing liver transplantation (LT) as a salvage procedure (SLT) in the event of HCC recurrence, is a debated strategy. From 1996 to 2005, we treated 227 cirrhotic patients with HCC transplantable: 80 LRs and 147 LTs of 293 listed for transplantation. Among 80 patients eligible for transplantation who underwent LR, 39 (49{\%}) developed HCC recurrence and 12/39 (31{\%}) of these patients presented HCC recurrence outside Milan criteria. Only 10 of the 39 patients underwent LT, a transplantation rate of 26{\%} of patients with HCC recurrence. According to intention-to-treat analysis of transplantable HCC patients who underwent LR (n = 80), compared to all those listed for transplantation (n = 293), 5-year overall survival was 66{\%} in the LR group versus 58{\%} in patients listed for LT, respectively (p = NS); 5-year disease-free survival was 41{\%} in the LR group versus 54{\%} in patients listed for LT (p = NS). Comparable 5-year overall (62{\%} vs. 73{\%}, p = NS) and disease-free (48{\%} vs. 71{\%}, p = NS) survival rates were obtained for SLT and primary LT for HCC, respectively. LR is a valid treatment for small HCC and in the event of recurrence, SLT is a safe and effective procedure.",
keywords = "Disease-free survival, Operative mortality, Outcome, Partial hepatectomy, Salvage transplantation",
author = "{Del Gaudio}, M. and G. Ercolani and M. Ravaioli and M. Cescon and A. Lauro and M. Vivarelli and M. Zanello and A. Cucchetti and G. Vetrone and F. Tuci and G. Ramacciato and Grazi, {G. L.} and Pinna, {A. D.}",
year = "2008",
month = "6",
doi = "10.1111/j.1600-6143.2008.02229.x",
language = "English",
volume = "8",
pages = "1177--1185",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection

T2 - University of Bologna experience

AU - Del Gaudio, M.

AU - Ercolani, G.

AU - Ravaioli, M.

AU - Cescon, M.

AU - Lauro, A.

AU - Vivarelli, M.

AU - Zanello, M.

AU - Cucchetti, A.

AU - Vetrone, G.

AU - Tuci, F.

AU - Ramacciato, G.

AU - Grazi, G. L.

AU - Pinna, A. D.

PY - 2008/6

Y1 - 2008/6

N2 - Liver resection (LR) for patients with small hepatocellular carcinoma (HCC) with preserved liver function, employing liver transplantation (LT) as a salvage procedure (SLT) in the event of HCC recurrence, is a debated strategy. From 1996 to 2005, we treated 227 cirrhotic patients with HCC transplantable: 80 LRs and 147 LTs of 293 listed for transplantation. Among 80 patients eligible for transplantation who underwent LR, 39 (49%) developed HCC recurrence and 12/39 (31%) of these patients presented HCC recurrence outside Milan criteria. Only 10 of the 39 patients underwent LT, a transplantation rate of 26% of patients with HCC recurrence. According to intention-to-treat analysis of transplantable HCC patients who underwent LR (n = 80), compared to all those listed for transplantation (n = 293), 5-year overall survival was 66% in the LR group versus 58% in patients listed for LT, respectively (p = NS); 5-year disease-free survival was 41% in the LR group versus 54% in patients listed for LT (p = NS). Comparable 5-year overall (62% vs. 73%, p = NS) and disease-free (48% vs. 71%, p = NS) survival rates were obtained for SLT and primary LT for HCC, respectively. LR is a valid treatment for small HCC and in the event of recurrence, SLT is a safe and effective procedure.

AB - Liver resection (LR) for patients with small hepatocellular carcinoma (HCC) with preserved liver function, employing liver transplantation (LT) as a salvage procedure (SLT) in the event of HCC recurrence, is a debated strategy. From 1996 to 2005, we treated 227 cirrhotic patients with HCC transplantable: 80 LRs and 147 LTs of 293 listed for transplantation. Among 80 patients eligible for transplantation who underwent LR, 39 (49%) developed HCC recurrence and 12/39 (31%) of these patients presented HCC recurrence outside Milan criteria. Only 10 of the 39 patients underwent LT, a transplantation rate of 26% of patients with HCC recurrence. According to intention-to-treat analysis of transplantable HCC patients who underwent LR (n = 80), compared to all those listed for transplantation (n = 293), 5-year overall survival was 66% in the LR group versus 58% in patients listed for LT, respectively (p = NS); 5-year disease-free survival was 41% in the LR group versus 54% in patients listed for LT (p = NS). Comparable 5-year overall (62% vs. 73%, p = NS) and disease-free (48% vs. 71%, p = NS) survival rates were obtained for SLT and primary LT for HCC, respectively. LR is a valid treatment for small HCC and in the event of recurrence, SLT is a safe and effective procedure.

KW - Disease-free survival

KW - Operative mortality

KW - Outcome

KW - Partial hepatectomy

KW - Salvage transplantation

UR - http://www.scopus.com/inward/record.url?scp=44449121383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44449121383&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2008.02229.x

DO - 10.1111/j.1600-6143.2008.02229.x

M3 - Article

C2 - 18444925

AN - SCOPUS:44449121383

VL - 8

SP - 1177

EP - 1185

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 6

ER -